Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer

Immunotherapy has led to an expansion of the treatment of malignancies, but its effect in prostate cancer (PCa) patients is modest. Chemoimmunotherapy is a promising approach that has attracted substantial attention. Although the widely used clinical chemotherapeutic drug doxorubicin (DOX) elicits i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhicheng, Sun, Chao, Wu, Haijun, Xie, Jizhen, Zhang, Tong, Li, Yumin, Xu, Xuelian, Wang, Peilin, Wang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686035/
https://www.ncbi.nlm.nih.gov/pubmed/34977528
http://dx.doi.org/10.1016/j.mtbio.2021.100189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686035/
https://www.ncbi.nlm.nih.gov/pubmed/34977528
http://dx.doi.org/10.1016/j.mtbio.2021.100189

Ejemplares similares